Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067769 · ClinicalTrials.gov registry record · NA
Internet-based Treatment of Early Childhood Fecal Incontinence
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT00067769: Completed NA study, sponsored by University of Virginia.
NCT00067769 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00067769, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
Encopresis, also known as fecal incontinence, is the voluntary or involuntary passage of stools causing soiling of clothes by a child over 4 years of age. The purpose of this study is to evaluate an Internet intervention for the treatment of encopresis.
Primary Outcome
Number of accidents per 2 week period
Interventions
- BEHAVIORAL Internet-based intervention UCanPoopToo
- BEHAVIORAL treatment as usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2003-10 |
| Est. Completion | 2007-07 |
| Phase | NA |
What the finished NCT00067769 record still lists
NCT00067769 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Internet-based intervention UCanPoopToo is the first listed.
NCT00067769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00067769 about?
NCT00067769 is a clinical study titled "Internet-based Treatment of Early Childhood Fecal Incontinence". Encopresis, also known as fecal incontinence, is the voluntary or involuntary passage of stools causing soiling of clothes by a child over 4 years of age. The purpose of this study is to evaluate an Internet intervention for the treatment of encopresis.
What is the current status of trial NCT00067769?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2003-10. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00067769?
The interventions under investigation include: Internet-based intervention UCanPoopToo (BEHAVIORAL), treatment as usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT00067769?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00067769's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia